TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 25079934

Group type: EXPERIMENTAL
Intervention: 2 g dose of cephalexin 30‐60 min before excision
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 21507197

Group type: EXPERIMENTAL
Intervention: 15 mg/kg dipyrone (D15 group)
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: 40 mg/kg dipyrone (D40 group)
Number of subjects: 162
Study: 19730804

Group type: EXPERIMENTAL
Intervention: Asacol (400‐4800 mg single dose)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Asacol (3600 mg/day for 7 days)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Asacol (single and multiple doses)
Number of subjects: 0
Study: 17312063

Group type: EXPERIMENTAL
Intervention: CT signs of internal hernia (mesenteric swirl, mushroom shape, etc.)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Combination of swirled mesentery and mushroom shape
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group (CT studies of 18 women without internal hernia)
Number of subjects: 18
Study: 15115713

Group type: EXPERIMENTAL
Intervention: leflunomide
Number of subjects: 100

Group type: COMPARATOR
Intervention: methotrexate
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: A77‐1726 (active metabolite of leflunomide)
Number of subjects: 100
Study: 12108885

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate (FP) 500 microg b.i.d. for 14 days
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 9934937

Group type: EXPERIMENTAL
Intervention: Fluoxetine 20 mg daily for up to 12 weeks
Number of subjects: 796

Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 796
Study: 7557091

Group type: EXPERIMENTAL
Intervention: rHb1.1
Number of subjects: 9

Group type: COMPARATOR
Intervention: human serum albumin
Number of subjects: 9
Study: 2138972

Group type: EXPERIMENTAL
Intervention: Water-based cutting fluids
Number of subjects: 23

Group type: COMPARATOR
Intervention: Neat oils
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Emulsifier component of cutting fluids
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Corrosion inhibitor component of cutting fluids
Number of subjects: 23
Study: 730419

Group type: EXPERIMENTAL
Intervention: Org GC 94 (45 mg/day for 14 days)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 30907005

Group type: EXPERIMENTAL
Intervention: Apixaban
Number of subjects: 251

Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 251
Study: 28545005

Group type: EXPERIMENTAL
Intervention: Trauma Management Therapy (TMT)
Number of subjects: 112
Study: 26501533

Group type: COMPARATOR
Intervention: naproxen + placebo
Number of subjects: 323

Group type: EXPERIMENTAL
Intervention: naproxen + cyclobenzaprine
Number of subjects: 323

Group type: EXPERIMENTAL
Intervention: naproxen + oxycodone/acetaminophen
Number of subjects: 323
Study: 23590237

Group type: EXPERIMENTAL
Intervention: Baseline interleukin-6 (IL-6) levels
Number of subjects: 650

Group type: EXPERIMENTAL
Intervention: Most recent IL-6 levels (near time of event)
Number of subjects: 650

Group type: COMPARATOR
Intervention: Mortality rate
Number of subjects: 650

Group type: COMPARATOR
Intervention: Causes of death
Number of subjects: 650

Group type: COMPARATOR
Intervention: Median time to death
Number of subjects: 650
Study: 22067848

Group type: EXPERIMENTAL
Intervention: Hilotherm
Number of subjects: 90

Group type: COMPARATOR
Intervention: Conventional cryotherapy
Number of subjects: 90

Group type: COMPARATOR
Intervention: No cryotherapy
Number of subjects: 90
Study: 19878089

Group type: EXPERIMENTAL
Intervention: Hysterectomy
Number of subjects: 236

Group type: EXPERIMENTAL
Intervention: LNG-IUS
Number of subjects: 236

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 236
Study: 15606550

Group type: EXPERIMENTAL
Intervention: High-dose cytotoxic treatment and autologous bone marrow transplantation
Number of subjects: 130

Group type: COMPARATOR
Intervention: No further treatment
Number of subjects: 130
Study: 10568870

Group type: EXPERIMENTAL
Intervention: Sucking an unflavored pacifier at a rate exceeding 30 sucks/min
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Combination of sucrose and nonnutritive sucking
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Procedures that eliminated crying and reduced heart rate
Number of subjects: 10
Study: 8738661

Group type: EXPERIMENTAL
Intervention: 1% amino acid dialysis solution (AA-P)
Number of subjects: 18

Group type: COMPARATOR
Intervention: 1.36% glucose dialysis solution (Glu-P)
Number of subjects: 18
Study: 1884189

Group type: EXPERIMENTAL
Intervention: Turning the patients' trunk to the left to compensate for saccadic reaction times (SRTs) towards left visual field (LVF) stimuli.
Number of subjects: 4

Group type: COMPARATOR
Intervention: Standard body position with midlines of head, trunk, and visual field oriented straight towards the middle of the projection screen.
Number of subjects: 4
Study: 7035052

Group type: EXPERIMENTAL
Intervention: Antihistamine-adrenergic combination
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study: 31893580

Group type: EXPERIMENTAL
Intervention: APO(a)‐LRx 20 mg every 4 weeks
Number of subjects: 286

Group type: EXPERIMENTAL
Intervention: APO(a)‐LRx 40 mg every 4 weeks
Number of subjects: 286

Group type: EXPERIMENTAL
Intervention: APO(a)‐LRx 20 mg every 2 weeks
Number of subjects: 286

Group type: EXPERIMENTAL
Intervention: APO(a)‐LRx 60 mg every 4 weeks
Number of subjects: 286

Group type: EXPERIMENTAL
Intervention: APO(a)‐LRx 20 mg every week
Number of subjects: 286

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 286
Study: 30628573

Group type: EXPERIMENTAL
Intervention: WASH intervention (improved water source, improved household sanitation, handwashing with soap)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control (deworming alone)
Number of subjects: 18
Study: 29193281

Group type: EXPERIMENTAL
Intervention: Enteral glutamine supplementation
Number of subjects: 61

Group type: COMPARATOR
Intervention: Control (alanine-supplemented enteral nutrition)
Number of subjects: 61
Study: 26842692

Group type: EXPERIMENTAL
Intervention: IV acetaminophen plus IV narcotics
Number of subjects: 100

Group type: COMPARATOR
Intervention: IV normal saline plus IV/PO narcotics
Number of subjects: 100
Study: 25461785

Group type: EXPERIMENTAL
Intervention: Face-to-face CBT-P
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Pure online self-help CBT-P
Number of subjects: 52

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 52
Study: 22616822

Group type: EXPERIMENTAL
Intervention: Spaced learning schedule
Number of subjects: 36

Group type: COMPARATOR
Intervention: Massed learning schedule
Number of subjects: 36

Group type: COMPARATOR
Intervention: Clumped learning schedule
Number of subjects: 36
Study: 19856443

Group type: EXPERIMENTAL
Intervention: 2D-accelerated autocalibrating parallel reconstruction method for Cartesian sampling (2D-ARC)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Conventional MRA method
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: 2D-ARC accelerated MRA
Number of subjects: 29
Study: 17222352

Group type: EXPERIMENTAL
Intervention: Imiquimod (local application, q12 applications for 2 or 4 days, or q24 hours for 4 or 8 days)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Vehicle cream (control group)
Number of subjects: 36
Study: 15818652

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided local corticosteroid injections (G1 group)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Standard local corticosteroid injections without ultrasound guidance (G2 group)
Number of subjects: 68
Study: 12164331

Group type: EXPERIMENTAL
Intervention: American journals
Number of subjects: 1997

Group type: COMPARATOR
Intervention: Japanese journals
Number of subjects: 1997
Study: 9801954

Group type: EXPERIMENTAL
Intervention: Multifaceted intervention including leadership support, training on CQI and prevention systems, consultation and networking opportunities
Number of subjects: 57

Group type: COMPARATOR
Intervention: Comparison clinics received similar assistance
Number of subjects: 57
Study: 7697275

Group type: EXPERIMENTAL
Intervention: BA + CS (combined beta 2‐agonist/corticosteroid therapy)
Number of subjects: 274

Group type: COMPARATOR
Intervention: BA + AC (combined beta 2‐agonist/anticholinergic therapy)
Number of subjects: 274

Group type: COMPARATOR
Intervention: BA + PL (beta 2‐agonist/placebo therapy)
Number of subjects: 274

Group type: EXPERIMENTAL
Intervention: BA + CS
Number of subjects: 274
Study: 30337747

Group type: EXPERIMENTAL
Intervention: Tibia cutting without guide group
Number of subjects: 76

Group type: COMPARATOR
Intervention: Tibia cutting with extramedullary guide group
Number of subjects: 76
Study: 28374186

Group type: EXPERIMENTAL
Intervention: Vitamin D3 (vD3) at 3750 U kg‐1, 18,750 U kg‐1, and 37,500 U kg‐1
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vitamin D3 (vD3) at 37,500 U kg‐1
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vitamin D3 (vD3) at various doses
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (0 U kg‐1)
Number of subjects: 0
Study: 26564934

Group type: EXPERIMENTAL
Intervention: Self-administered CISS
Number of subjects: 118

Group type: COMPARATOR
Intervention: Practitioner-administered CISS
Number of subjects: 118

Group type: COMPARATOR
Intervention: Normal Binocular Vision (NBV)
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Convergence Insufficiency (CI)
Number of subjects: 118
Study: 23179148

Group type: EXPERIMENTAL
Intervention: Metallic stent covered with a paclitaxel-incorporated membrane (MSCPM)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Covered metal stent (CMS)
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: MSCPM
Number of subjects: 106

Group type: COMPARATOR
Intervention: CMS
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Gemcitabine-based chemotherapy
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: MSCPM and CMS
Number of subjects: 106
Study: 21232139

Group type: EXPERIMENTAL
Intervention: Daily intake of beef as a complementary food for 12 months
Number of subjects: 600

Group type: COMPARATOR
Intervention: Micronutrient fortified equi‐caloric rice‐soy cereal supplement for 12 months
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Nutrition education messages delivered to mothers
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Anthropometry measurements at 6, 9, 12, and 18 months
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Biomarkers of iron, zinc, and Vitamin B12 status at 18 months
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Neurocognitive development assessments at 12 and 18 months
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Incidence of infectious morbidity throughout the trial
Number of subjects: 600
Study: 18625000

Group type: EXPERIMENTAL
Intervention: Strontium ranelate (SR)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Calcium and vitamin D (control)
Number of subjects: 22
Study: 17709062

Group type: EXPERIMENTAL
Intervention: Trigger point acupuncture (TrP, n=10)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard acupuncture (SA, n=10)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Non-trigger point acupuncture (non-TrP, n=10)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sham treatment (SH, n=10)
Number of subjects: 40
Study: 15577425

Group type: EXPERIMENTAL
Intervention: Micronutrient supplementation (multivitamin plus selenium)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 400
Study: 11238476

Group type: EXPERIMENTAL
Intervention: Radioactive iodine (131I) therapy (4.44 MBq/g thyroid)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Suppressive levothyroxine treatment aiming at TSH values between 0.01 and 0.1 mU/L
Number of subjects: 64

Group type: COMPARATOR
Intervention: Suppressive levothyroxine treatment
Number of subjects: 64
Study: 9610558

Group type: EXPERIMENTAL
Intervention: Maximal androgen blockade
Number of subjects: 3500

Group type: EXPERIMENTAL
Intervention: Global collaboration and megatrials
Number of subjects: 3500
Study: 8113560

Group type: EXPERIMENTAL
Intervention: Quantitative two-dimensional echocardiography
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: ECG criteria for right atrial enlargement
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: P pulmonale
Number of subjects: 100
Study: 3384075

Group type: EXPERIMENTAL
Intervention: Bambuterol 30 mg once daily
Number of subjects: 25

Group type: COMPARATOR
Intervention: Terbutaline 5 mg sustained-release twice daily
Number of subjects: 25
Study: 29729588

Group type: EXPERIMENTAL
Intervention: 20 mg of fluoxetine
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 28527625

Group type: EXPERIMENTAL
Intervention: Cosmetic micromanipulation (CM)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Sham (laser assisted zona hatching only)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 96
Study: 26711065

Group type: EXPERIMENTAL
Intervention: Flurbiprofen axetil
Number of subjects: 63

Group type: COMPARATOR
Intervention: Ibuprofen
Number of subjects: 63

Group type: COMPARATOR
Intervention: Celecoxib
Number of subjects: 63
Study: 23176966

Group type: EXPERIMENTAL
Intervention: Catheter-directed thrombolysis (CDT)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Catheter-directed thrombolysis (CDT) via popliteal access
Number of subjects: 92
Study: 21989724

Group type: EXPERIMENTAL
Intervention: Narafilcon A SCL
Number of subjects: 31

Group type: COMPARATOR
Intervention: Etafilcon A SCL
Number of subjects: 31
Study: 18319414

Group type: EXPERIMENTAL
Intervention: Conjugated equine estrogens (CEE) 0.625 mg daily plus medroxyprogesterone acetate (MPA) 2.5 mg daily
Number of subjects: 15730

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15730
Study: 16563608

Group type: EXPERIMENTAL
Intervention: Laparoscopic prostatectomy (LRP)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Open radical retropubic prostatectomy (RRP)
Number of subjects: 120
Study: 12741340

Group type: EXPERIMENTAL
Intervention: Sublingual administration of Sildenafil citrate (crushed and dissolved under the tongue) 15 minutes before planned sexual relations
Number of subjects: 30

Group type: COMPARATOR
Intervention: Oral administration of Sildenafil citrate (50-100 mg) 30 minutes before planned sexual relations
Number of subjects: 30
Study: 10800431

Group type: EXPERIMENTAL
Intervention: Brief intervention (9-minute video, 12 to 15 minutes of behavioral counseling, clinician advice to quit, follow-up telephone calls)
Number of subjects: 1154

Group type: COMPARATOR
Intervention: Advice only (control group)
Number of subjects: 1154

Group type: EXPERIMENTAL
Intervention: Brief intervention
Number of subjects: 1154
Study: 8618764

Group type: EXPERIMENTAL
Intervention: Pretreatment with one drop of diclofenac sodium 0.1% four times per day for 3 days before surgery plus one drop of diclofenac sodium 0.1% every 15 minutes for four doses, beginning 1 hour before surgery.
Number of subjects: 60

Group type: COMPARATOR
Intervention: No pretreatment, but one drop of diclofenac sodium 0.1% every 15 minutes for four doses beginning 1 hour before surgery.
Number of subjects: 60

Group type: COMPARATOR
Intervention: No diclofenac sodium drops at all before surgery.
Number of subjects: 60
Study: 1598878

Group type: EXPERIMENTAL
Intervention: Doppler valve area measurement before and after aortic balloon valvuloplasty
Number of subjects: 1197

Group type: EXPERIMENTAL
Intervention: Invasive valve area measurement before and after aortic balloon valvuloplasty
Number of subjects: 1197

Group type: EXPERIMENTAL
Intervention: Doppler valve area measurement before and after mitral balloon valvuloplasty
Number of subjects: 1197

Group type: EXPERIMENTAL
Intervention: Invasive valve area measurement before and after mitral balloon valvuloplasty
Number of subjects: 1197
Study: 6377118

Group type: EXPERIMENTAL
Intervention: iohexol 300 mg I/ml
Number of subjects: 54

Group type: COMPARATOR
Intervention: Hexabrix 320 mg I/ml
Number of subjects: 54
Study: 30144264

Group type: EXPERIMENTAL
Intervention: Structured self-monitoring of blood glucose (SMBG)
Number of subjects: 250

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 250
Study: 29494371

Group type: EXPERIMENTAL
Intervention: Supportive‐educational nurse‐led intervention
Number of subjects: 160

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 160
Study: 27362551

Group type: EXPERIMENTAL
Intervention: Transcatheter hepatic arterial chemoembolization (group A)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Radiofrequency thermal ablation combined with transcatheter arterial chemoembolization (group B)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Microwave ablation combined with transcatheter arterial chemoembolization (group C)
Number of subjects: 50
Study: 24555511

Group type: EXPERIMENTAL
Intervention: Mentalization Based Therapy for Eating Disorders (MBT-ED)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Specialist Supportive Clinical Management (SSCM-ED)
Number of subjects: 0
Study: 22314329

Group type: EXPERIMENTAL
Intervention: Perioperative FOLFOX chemotherapy
Number of subjects: 342

Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 342
Study: 20190349

Group type: COMPARATOR
Intervention: Glucose solution (50 g glucose)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Griffin's Fruitli bar (50 g available carbohydrate)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Peak Fuel's Summit bar (50 g available carbohydrate)
Number of subjects: 20
Study: 18059578

Group type: EXPERIMENTAL
Intervention: Pre-test carbohydrate ingestion (CHO, 2x300 mL, 7% solution)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo (Pl) ingestion
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Pre-test carbohydrate ingestion (CHO)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo (Pl)
Number of subjects: 15
Study: 15012171

Group type: COMPARATOR
Intervention: Pioglitazone 30 mg/day
Number of subjects: 270

Group type: COMPARATOR
Intervention: Pioglitazone 7.5/15/30 mg/day or 15/30/45 mg/day
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Pioglitazone added to sulfonylurea
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Pioglitazone added to metformin
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Pioglitazone added to insulin
Number of subjects: 270

Group type: COMPARATOR
Intervention: Pioglitazone monotherapy
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Pioglitazone combined with sulfonylurea
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Pioglitazone combined with metformin
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Pioglitazone combined with insulin
Number of subjects: 270
Study: 11666121

Group type: EXPERIMENTAL
Intervention: TTFCA 60 mg thrice daily for 2 days before the flight, the day of the flight, and for another day after the flight
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no drug or other treatment)
Number of subjects: 0
Study: 9733274

Group type: EXPERIMENTAL
Intervention: Patient-controlled analgesia (PCA) with intravenous diamorphine
Number of subjects: 65

Group type: COMPARATOR
Intervention: Continuous infusion (CI) with intravenous diamorphine
Number of subjects: 65
Study: 8061476

Group type: EXPERIMENTAL
Intervention: Pre-retirement planning intervention
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control group (age peers)
Number of subjects: 75
Study: 2923765

Group type: EXPERIMENTAL
Intervention: 1.5% enflurane
Number of subjects: 113

Group type: COMPARATOR
Intervention: 1.25% isoflurane
Number of subjects: 113
Study: 31568288

Group type: EXPERIMENTAL
Intervention: Large-gel-particle hyaluronic acid with 0.3% lidocaine, 20 mg/ml
Number of subjects: 90

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 90
Study: 28940301

Group type: EXPERIMENTAL
Intervention: Tibetan yoga program (TYP)
Number of subjects: 227

Group type: COMPARATOR
Intervention: Stretching program (STP)
Number of subjects: 227
Study: 26818364

Group type: EXPERIMENTAL
Intervention: 30% sucrose solution
Number of subjects: 114

Group type: COMPARATOR
Intervention: Placebo (water)
Number of subjects: 114
Study: 24819671

Group type: EXPERIMENTAL
Intervention: Heated cigarette (HC)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Conventional cigarette (CC10)
Number of subjects: 70
Study: 21470389

Group type: EXPERIMENTAL
Intervention: Higher systolic blood pressure (SBP) ≥160 mmHg
Number of subjects: 711

Group type: EXPERIMENTAL
Intervention: Body mass index (BMI) ≥30
Number of subjects: 711

Group type: EXPERIMENTAL
Intervention: Retinopathy prevalence
Number of subjects: 711

Group type: EXPERIMENTAL
Intervention: Hypertension and obesity
Number of subjects: 711

Group type: EXPERIMENTAL
Intervention: Long-term, short-term or current glycaemia
Number of subjects: 711
Study: 20712499

Group type: EXPERIMENTAL
Intervention: Internet-based self-administered program
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Therapist-applied program
Number of subjects: 127

Group type: COMPARATOR
Intervention: Waiting-list control group
Number of subjects: 127
Study: 17703152

Group type: EXPERIMENTAL
Intervention: Aldehyde test (AT)
Number of subjects: 150
Study: 15890106

Group type: EXPERIMENTAL
Intervention: Postoperative adjuvant chemotherapy
Number of subjects: 6518

Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 6518
Study: 12476093

Group type: EXPERIMENTAL
Intervention: Verteporfin therapy (6 mg/m² body surface area)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Verteporfin therapy (6 to 20 mg/m²)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Verteporfin therapy
Number of subjects: 47
Study: 10423707

Group type: EXPERIMENTAL
Intervention: 20-30 mmol/day of oral magnesium hydroxide
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 28
Study: 7498228

Group type: EXPERIMENTAL
Intervention: 99mTc-HMPAO labelled leucocytes
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: 111In-human immunoglobulin (IgG)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Comparison of both agents
Number of subjects: 27
Study: 2252453

Group type: EXPERIMENTAL
Intervention: Physostigmine treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Patients with progressive supranuclear palsy
Number of subjects: 0
Study: 6773843

Group type: EXPERIMENTAL
Intervention: Disodium cromoglycate (1.2 g/day)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 31065881

Group type: EXPERIMENTAL
Intervention: Daily partner‐focused petitionary prayer (PFPP)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Waitlist
Number of subjects: 90

Group type: COMPARATOR
Intervention: Meditation
Number of subjects: 90